Cleveland Clinic has secured leadership in a quantum computing project spearheaded by nonprofit company Wellcome Leap and is set to make substantial contributions to a separate initiative in collaboration with Algorithmiq.
Cleveland Clinic received the two contracts through Wellcome Leap's Quantum for Bio Challenge, which will allocate a sum of up to $40 million to a global cohort of 12 researchers who are dedicated to advancing quantum computing applications in healthcare, according to an Oct. 24 news release from Cleveland Clinic. Both contracts will be in collaboration with IBM Quantum.
Cleveland Clinic and IBM teams will join forces within the framework of the Cleveland Clinic-IBM Discovery Accelerator. Together, they will work in close collaboration on one project and combine their efforts with Algorithmiq for a second project.
In the first, Cleveland Clinic will work with IBM Quantum experts to create quantum algorithms and workflows for more precise and rapid protein structure prediction.
In the second, IBM Quantum, Cleveland Clinic and Algorithmiq will jointly develop computational tools to investigate the potential of quantum computing in cancer drug development.
This project will utilize Algorithmiq's Aurora platform, powered by IBM's quantum hardware, alongside Cleveland Clinic's drug application expertise to showcase quantum advantage in creating photon-activated cancer drugs.
To date, Cleveland Clinic has launched more than 30 projects with IBM.